Combination therapy comprising SGLT inhibitors and DPP4 inhibitors

• 收藏
• 分享

专利权人:

Mitsubishi Tanabe Pharma Corporation

发明人:

Arakawa, Kenji,Ueta, Kiichiro,Matsushita, Yasuaki

申请号：

AU2009205060

公开号：

AU2009205060B2

申请日:

2009.01.16

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The present invention relates to combination therapy comprising a DPP4 inhibitorand an SGLT inhibitor. The combination of the present invention leads to increaseplasma GLP-1 level and the combination is useful for prevention or treatmentof conditions such as diabetes and diseases related to diabetes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/